Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dina, Sikpa"'
Autor:
Jérémie P, Fouquet, Dina, Sikpa, Réjean, Lebel, Renat, Sibgatulin, Martin, Krämer, Karl-Heinz, Herrmann, Andreas, Deistung, Luc, Tremblay, Jürgen R, Reichenbach, Martin, Lepage
Publikováno v:
Magnetic Resonance Imaging. 92:67-81
Microparticles of iron oxide (MPIOs) are increasingly used for contrast generation in magnetic resonance imaging (MRI). In particular, Dynabeads® MyOne™ Tosylactivated MPIOs have enabled sensitive and targeted molecular imaging, e.g., to detect va
Autor:
Dina Sikpa, Lisa Whittingstall, Martin Savard, Réjean Lebel, Jérôme Côté, Stephen McManus, Sylvain Chemtob, David Fortin, Martin Lepage, Fernand Gobeil
Publikováno v:
Pharmaceuticals, Vol 13, Iss 10, p 279 (2020)
The blood–brain barrier (BBB) is a major obstacle to the development of effective diagnostics and therapeutics for brain cancers and other central nervous system diseases. Peptide agonist analogs of kinin B1 and B2 receptors, acting as BBB permeabi
Externí odkaz:
https://doaj.org/article/1f234223d2b34d019185c362e5097d44
Autor:
Jérémie P. Fouquet, Dina Sikpa, Maxime Richer, Réjean Lebel, Martin Lepage, Phedias Diamandis
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
Scientific Reports
Advances in digital whole-slide imaging and machine learning (ML) provide new opportunities for automated examination and quantification of histopathological slides to support pathologists and biologists. However, implementation of ML tools often req
Autor:
Réjean Lebel, Dina Sikpa, Martin Lepage, Jérôme Côté, Stephen McManus, Martin Savard, Sylvain Chemtob, Fernand Gobeil, David Fortin, Lisa Whittingstall
Publikováno v:
Pharmaceuticals, Vol 13, Iss 279, p 279 (2020)
Pharmaceuticals
Volume 13
Issue 10
Pharmaceuticals
Volume 13
Issue 10
The blood&ndash
brain barrier (BBB) is a major obstacle to the development of effective diagnostics and therapeutics for brain cancers and other central nervous system diseases. Peptide agonist analogs of kinin B1 and B2 receptors, acting as BBB
brain barrier (BBB) is a major obstacle to the development of effective diagnostics and therapeutics for brain cancers and other central nervous system diseases. Peptide agonist analogs of kinin B1 and B2 receptors, acting as BBB
Autor:
Adrianna Radulska, Dina Sikpa, Jérémie P. Fouquet, Martin Lepage, Lisa Whittingstall, Benoit Paquette, Réjean Lebel, Luc Tremblay
Publikováno v:
International journal of cancerReferences. 147(1)
Brain metastases are the most prevalent intracranial malignancy. Patient outcome is poor and treatment options are limited. Hence, new avenues must be explored to identify potential therapeutic targets. Inflammation is a known critical component of c
Autor:
Dina Sikpa, Lisa Whittingstall, Jérémie P. Fouquet, Luc Tremblay, Réjean Lebel, Martin Lepage
Publikováno v:
Cancer Research. 79:86-86
BACKGROUND: Brain metastases (BM) are the most prevalent intracranial neoplasm. Inflammation is central to the development of cancer. While an intra-tumoral inflammatory microenvironment contributes to the acquisition of malignant phenotypes and lead
Autor:
Nikta Zarif Yussefian, Mathieu Letendre-Jauniaux, Réjean Lebel, Yves Bérubé-Lauzière, Dina Sikpa
Publikováno v:
Biomedical Optics 2014.
We present hardware and software developments on a unique continuous-wave molecular scanner to endow it with capabilities to localize fluorescence and bioluminescence signals. Initial results obtained in bioluminescence experiments are presented.